Quick Answer
BIO-RAD LABORATORIES, INC. reported Operating Income Loss of $47.20 million for the year ending 2025.
- BIO-RAD LABORATORIES, INC. showed a decrease of -82.5% in Operating Income Loss from 2024 to 2025.
- This data is from BIO-RAD LABORATORIES, INC.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $74.80 million | Q1 2011: $67.12 million | Q2 2011: $68.19 million | Q3 2011: $73.92 million | Q1 2012: $54.37 million | Q2 2012: $73.31 million | Q3 2012: $65.84 million | Q1 2013: $35.15 million | Q2 2013: $52.93 million | Q3 2013: $29.06 million | Q1 2014: $20.47 million | Q2 2014: $45.69 million | Q3 2014: $33.24 million | Q1 2015: $34.35 million | Q2 2015: $40.21 million | Q3 2015: $32.67 million | Q1 2016: $20.20 million | Q2 2016: $26.90 million | Q3 2016: $22.70 million | Q4 2016: -$28.20 million | Q1 2017: $26.21 million | Q2 2017: -$1.70 million | Q3 2017: $38.76 million | Q4 2017: $45.90 million | Q1 2018: $43.65 million | Q2 2018: $43.79 million | Q3 2018: $36.28 million | Q1 2019: $56.61 million | Q2 2019: $56.39 million | Q3 2019: $57.46 million | Q1 2020: $74.37 million | Q2 2020: $51.74 million | Q3 2020: $109.60 million | Q1 2021: $100.86 million | Q2 2021: $124.78 million | Q3 2021: $156.80 million | Q1 2022: $146.41 million | Q2 2022: $122.89 million | Q3 2022: $94.65 million | Q1 2023: $61.91 million | Q2 2023: $89.62 million | Q3 2023: $90.95 million | Q1 2024: $44.60 million | Q2 2024: $101.50 million | Q3 2024: $64.50 million | Q1 2025: $23.70 million | Q2 2025: $77.10 million | Q3 2025: $65.30 million.
- Over the full 18 years of available data (2008 to 2025), BIO-RAD LABORATORIES, INC.'s Operating Income Loss has declined by 74.2%.
- Historical annual values: Fiscal year 2025: $47.20 million | Fiscal year 2024: $269.00 million | Fiscal year 2023: $337.80 million | Fiscal year 2022: $482.60 million | Fiscal year 2021: $500.34 million | Fiscal year 2020: $421.33 million | Fiscal year 2019: $229.66 million | Fiscal year 2018: -$103.34 million | Fiscal year 2017: $119.25 million | Fiscal year 2016: $55.72 million | Fiscal year 2015: $166.71 million | Fiscal year 2014: $149.98 million | Fiscal year 2013: $169.46 million | Fiscal year 2012: $264.18 million | Fiscal year 2011: $305.24 million | Fiscal year 2010: $284.01 million | Fiscal year 2009: $230.99 million | Fiscal year 2008: $182.94 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: